Brief: Bellerophon Therapeutics reports Q2 results
15/08/2022 13:49
Aug 15 (Reuters) - Bellerophon Therapeutics Inc BLPH.O :
* BELLEROPHON PROVIDES CLINICAL PROGRAM UPDATE AND REPORTS
SECOND
QUARTER 2022 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.43
Source text for Eikon: ID:nGNX6VljW7
Further company coverage: BLPH.O
Recent news on Bellerophon Therapeutics
See all newsBrief: Bellerophon Therapeutics Inc On October 12, 2023, Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners
U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen